IP Library Granted Patent US 9,440,051
Granted Patent B2
US 9,440,051 · App. 13/658,125 · Granted Sep 13, 2016

Inserter for a multiplicity of subcutaneous parts

Inventor: Steffen Gyrn (Ringsted, DK)
Assignee: UNOMEDICAL A/S
A61M25/0612A61B5/1411A61B5/150022A61B5/15105A61B5/15113A61B5/15117A61B5/15144A61B5/15151A61B5/15163A61B5/15176A61B5/150435A61B5/150519A61B5/150564A61B5/150717A61M5/158A61M25/0631A61M2005/004
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,440,051
App. No.
13/658,125
Granted
Sep 13, 2016
Kind
B2
Abstract

A holding device and an inserter are provided. The holding device includes a casing providing a cavity including walls, the was encompass a subcutaneous unit. The cavity includes a first side having an outlet opening, the outlet opening before use is covered with a penetrable or removable cover, and a second side comprising a layer having an outer surface and being penetrable, removable or flexible to transfer an impact from outside the layer to the subcutaneous unit. The casing includes a releasable attachment member corresponding to a member on the subcutaneous unit and a needle secured to the casing. An impact towards the outer surface of the layer pushes the subcutaneous unit at least partly out of the casing into a subcutaneous position, when the unit is in the subcutaneous position the releasable attachment member of the casing is released allowing detachment of the unit from the casing.

Claims (7)

1. A holding device holding subcutaneous units under sterile conditions, the holding device comprising: a casing providing at least two closed cavities each comprising walls where the walls encompass a subcutaneous unit, each cavity having a first side comprising an outlet opening, the outlet opening before use is covered with a penetrable or removable cover, and a second side comprising a layer having an outer surface and being penetrable in order to transfer an impact from outside the layer to the held subcutaneous unit, the casing comprising a needle upon which the subcutaneous unit is releasably attached and a spring unit providing retraction of the needle after insertion of the subcutaneous unit, the needle extending from a needle hub retained in each cavity; wherein an impact towards the outer surface of the layer of the second side pushes the subcutaneous unit and the needle at least partly out of the casing and into a subcutaneous position, when the subcutaneous unit is released from the needle allowing detachment of the subcutaneous unit from the casing.

2. The holding device according to claim 1 , wherein the holding device comprises an attachment hub attaching the holding device to and interacting with an inserter able to provide an impact toward the outer surface of the layer of the second side of the casing.

3. The holding device according to claim 1 , wherein the spring unit comprises an elastic unit positioned between the distal end of the needle or of a proximal surface of a needle hub to which the needle is attached and the first side such that the elastic unit pushes the needle into a retracted position after detachment of the subcutaneous unit.

4. The holding device according to claim 1 , wherein the subcutaneous unit is configured to be attached to an infusion site at a point during insertion of the subcutaneous unit where the subcutaneous unit has reached a final subcutaneous position, wherein the infusion site before insertion comprises at least a part of or the complete first side of the holding device and the infusion site is provided with a mounting pad to permanently attach the infusion site to the patient's skin surface.

5. The holding device according to claim 4 , wherein a proximal side of the subcutaneous unit is configured to be attached to the infusion site at a point during insertion of the subcutaneous unit where the subcutaneous unit has reached a final subcutaneous position.

6. The holding device according to claim 4 , wherein the casing comprises guiding parts corresponding to receiving or guiding parts of the infusion site, where joining of the corresponding guiding parts ensures correct positioning of the casing before insertion relative to the infusion site.

7. The holding device according to claim 1 , wherein the subcutaneous unit comprises a body part, the body part after detachment from the holding device is positioned above the patient's skin surface and a longish part which after detachment from the holding device is positioned below the patient's skin surface in a depth below the skin surface between about 1-15 mm.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Oct 25, 2019
From: WILMINGTON TRUST (LONDON) LIMITED
To: CONVATEC INC.; UNOMEDICAL A/S; UNOMEDICAL LIMITED
Reel/Frame 050831/0073 →
SECURITY AGREEMENT Recorded Nov 3, 2016
From: CONVATEC LIMITED; UNOMEDICAL A/S; UNOMEDICAL LIMITED
To: WILMINGTON TRUST (LONDON) LIMITED, AS COLLATERAL AGENT
Reel/Frame 040551/0956 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2013
From: GYRN, STEFFEN
To: UNOMEDICAL A/S
Reel/Frame 029757/0333 →
Priority Claims (1)
EP 11186868 · Oct 27, 2011 · regional
Continuity (2)
Provisional Application 61552085 · Oct 27, 2011
Related Publication 20130110047A1 · May 2, 2013